News
$NeuroSense Therapeutics (NRSN.US)$ Reuters· 3 mins ago
Neurosense Therapeutics Granted Key U.S. Patent for Novel Primec Formulation, Its Lead Asset for ALS and Alzheimer's
Neurosense Therapeutics Granted Key U.S. Patent for Novel Primec Formulation, Its Lead Asset for ALS and Alzheimer's
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
